Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitric oxide donors are pharmacologically active substances that release nitric oxide (NO), a critical signaling molecule involved in numerous physiological and pathophysiological processes, especially within the cardiovascular system. These compounds serve as exogenous sources of NO, promoting vasodilation, inhibiting platelet aggregation, and influencing cardiac function.
Release of nitric oxide (NO) or related species that activate soluble guanylyl cyclase (sGC), increasing cyclic guanosine monophosphate (cGMP) levels, leading to activation of cGMP-dependent protein kinases and reduced intracellular calcium concentrations, resulting in vasodilation and inhibition of platelet aggregation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric Oxide Donor (None).